These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26824352)

  • 1. Neighbourhood Deprivation and Outcomes of Stop Smoking Support--An Observational Study.
    Brose LS; McEwen A
    PLoS One; 2016; 11(1):e0148194. PubMed ID: 26824352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Term Smoking Cessation in English Resident Adults of Bangladeshi Origin: A Service Review.
    Kassim S; Al-Haboubi M; Croucher R
    Nicotine Tob Res; 2016 Apr; 18(4):410-5. PubMed ID: 25957437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neighbourhood deprivation and smoking and quit behaviour among smokers in Mexico: findings from the ITC Mexico Survey.
    Fleischer NL; Thrasher JF; Sáenz de Miera Juárez B; Reynales-Shigematsu LM; Arillo-Santillán E; Osman A; Siahpush M; Fong GT
    Tob Control; 2015 Jul; 24 Suppl 3(Suppl 3):iii56-iii63. PubMed ID: 25170022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the use of aids to cessation in English smokers.
    Kotz D; Fidler J; West R
    Addiction; 2009 Aug; 104(8):1403-10. PubMed ID: 19549267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of quit success in Belgian participants of a varenicline observational smoking cessation study.
    Boudrez H; Hoengenaert JP; Nackaerts K; Messig M; Metcalfe M
    Acta Clin Belg; 2013; 68(1):37-42. PubMed ID: 23627193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The English smoking treatment services: one-year outcomes.
    Ferguson J; Bauld L; Chesterman J; Judge K
    Addiction; 2005 Apr; 100 Suppl 2():59-69. PubMed ID: 15755262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of success for smoking cessation at the workplace: a longitudinal study.
    Stolz D; Scherr A; Seiffert B; Kuster M; Meyer A; Fagerström KO; Tamm M
    Respiration; 2014; 87(1):18-25. PubMed ID: 23594795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers.
    Yang M; Chen H; Johnson ML; Essien EJ; Peters RJ; Wu IH; Abughosh SM
    Subst Use Misuse; 2015; 50(13):1628-37. PubMed ID: 26595661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended varenicline treatment in a severe cardiopathic cigarette smoker: a case report.
    Munarini E; Marabelli C; Pozzi P; Boffi R
    J Med Case Rep; 2015 Feb; 9():29. PubMed ID: 25971250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
    Cabezas C; Advani M; Puente D; Rodriguez-Blanco T; Martin C;
    Addiction; 2011 Sep; 106(9):1696-706. PubMed ID: 21561497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life effectiveness of smoking-cessation treatments in general practice clinics in Denmark. The Escape Smoke project.
    Poulsen PB; Spillemose H; Nielsen G; Hergel LL; Wedell-Wedellsborg D; Strand M; Ringbæk T
    Respir Med; 2015 Feb; 109(2):218-27. PubMed ID: 25592244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summaries for Patients. Behavioral and Pharmacologic Treatments to Help Adults Quit Smoking: U.S. Preventive Services Task Force Recommendation Statement.
    Ann Intern Med; 2015 Oct; 163(8):I-40. PubMed ID: 26389837
    [No Abstract]   [Full Text] [Related]  

  • 19. Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study.
    West R; Zhou X
    Thorax; 2007 Nov; 62(11):998-1002. PubMed ID: 17573444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of neighbourhood disadvantage on smoking cessation and its contribution to inequalities in smoking status.
    Turrell G; Hewitt BA; Miller SA
    Drug Alcohol Rev; 2012 Jul; 31(5):645-52. PubMed ID: 22507105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.